Investors
In its second and third rounds of financing in June 2006 and September 2007, Tengion raised $83 million, with funding from top biotech equity investors.
 |
 |
 |
 |
 |
 |
 |
 |
 |
Featured Information
Latest News
- September 22, 2008: Tengion Announces Expanded European Orphan Medicinal Product Designation for Neo-Bladder Augment
- September 22, 2008: Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
- September 19, 2008: Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
- September 18, 2008: Tengion Scientists Publish Positive Preclinical Findings with Neo-Organ Demonstrating Long-term Durability and Growth with Skeletal Maturation